top of page

ABOLOGIX founded in Geneva, Switzerland

  • branding425
  • Jan 25, 2018
  • 1 min read

Updated: Feb 28

Geneva, Switzerland, January 25, 2018 – Abologix, a privately held swiss biotechnology company developing novel immuno-oncology products for the benefit of cancer patients has been founded in Geneva, Switzerland by Dr. Ignacio Faus, Prof. Beat Imhof (University of Geneva) and Prof. Thomas Matthes (Geneva University Hospital ).

 
 
 

Comments


bottom of page